Presence of a β(II) protein kinase C-selective nuclear membrane activation factor in human leukemia cells

In human promyelocytic (HL60) leukemia cells β(II) protein kinase C (PKC) is selectively translocated to the nucleus in response to proliferative stimuli. At the nucleus, β(II) PKC directly phosphorylates the nuclear envelope polypeptide lamin B at two consensus PKC phosphorylation sites, Ser³⁹⁵ and Ser⁴⁰⁵. Phosphorylation of these sites by β(II) PKC leads to solubilization of lamin B indicative of mitotic nuclear envelope breakdown in vitro (Hocevar, B. A., Burns, D. J., and Fields, A. P. (1993) J. Biol. Chem. 268, 7545-7552). We have now investigated the molecular basis for β(II) PKC-selective nuclear translocation and lamin B phosphorylation using an in vitro reconstitution system. We find that β(II) PKC phosphorylates nuclear envelope lamin B at 10-20 times the rate of α PKC, whereas both kinases phosphorylate soluble lamin B at similar rates. Comparative tryptic phosphopeptide analysis demonstrates that α PKC and β(II) PKC phosphorylate identical sites, Ser³⁹⁵ and Ser⁴⁰⁵, on soluble lamin B. These data suggest that a component(s) of the nuclear envelope confers β(II) PKC- selective nuclear activation and lamin B phosphorylation. Extraction of nuclear envelopes with either non-ionic detergent (2% n-octyl glucoside) or organic solvent (CHCl₃/CH₃OH/H₂O; 10:10:3) abolishes β(II) PKC-selective phosphorylation of nuclear lamin B. Nuclear membrane extracts reconstitute β(II) PKC-selective phosphorylation, indicating the presence of a β(II) PKC-selective nuclear membrane activation factor (NMAF). NMAF selectively activates β(II) PKC histone H1 kinase activity 3-4-fold above the level achieved with optimal concentrations of Ca²⁺, diacylglycerol, and phosphatidylserine. Finally, NMAF activity is not affected by exhaustive protease treatment, suggesting that it is a nuclear membrane lipid(s) or lipid metabolite. These data suggest that NMAF plays a physiologic role in the nuclear activation of β(II) PKC.